|
Articles |
| 1131 |
Raloxifene: A Selective
Estrogen Receptor Modulator
JANINE A. SCOTT, M.D.,
CARLOS C. DA CAMARA, PHARM.D., and J. ELIZABETH EARLY, PHARM.D.
Raloxifene augments bone mineral density and lowers total and low-density
lipoprotein cholesterol levels. Its effects on fracture risk and its ability to
protect against cardiovascular disease have yet to be determined. Also
unestablished is the effect of raloxifene on the incidence of breast and
endometrial cancer. |
 |
Patient information:
"Raloxifene and Osteoporosis," p. 1139 |
| 1143 |
Evaluation of Asymptomatic
Microscopic Hematuria in Adults
TIMOTHY R.
THALLER, M.D., and LESTER P. WANG, M.D.
Using a systematic
diagnostic approach, the family physician can determine the cause of
asymptomatic microscopic hematuria in nearly 80 percent of patients. |
|
Patient information:
"Microscopic Hematuria," p. 1154 |
| 1159 |
Newer Pharmacologic
Alternatives for Erectile Dysfunction
ANTHONY J.
VIERA, LT, MC, USNR, TIMOTHY L. CLENNEY, LCDR, MC, USNR, DONALD W.
SHENENBERGER, LT, MC, USNR, and GORDON F. GREEN, CDR, MC, USNR
Newer and more acceptable pharmacotherapies for erectile dysfunction have
prompted more men to seek such treatment. Family physicians are in a good
position to diagnose and treat this common disorder. |
|
Patient information:
"Erectile Dysfunction," p. 1169 |
|
Patient information:
"Using Viagra," p. 1172 |
| 1175 |
Outpatient Detoxification of
the Addicted or Alcoholic Patient
CHRISTOPHER D.
PRATER, M.D., KARL E. MILLER, M.D., and ROBERT G. ZYLSTRA, ED.D.,
L.C.S.W.
Outpatient detoxification, including the management of
acute withdrawal and long-term recovery, can usually be performed safely and
effectively by family physicians. |
|
Patient information: "Do
You Have a Problem with Alcohol or Drugs?," p. 1183 |
| 1185 |
Angiotensin II Receptor
Antagonists in the Treatment of Hypertension
NORMAN M. KAPLAN, M.D.
Until further data are available,
angiotensin II receptor antagonists may be an alternative to
angiotensin-converting enzyme (ACE) inhibitors in patients who cannot tolerate
ACE inhibitors and who have comorbid conditions for which ACE inhibitors have
shown benefit. |
| 1191 |
Atopic Dermatitis: A Review
of Diagnosis and Treatment
CHRISTINE E. CORREALE,
M.D., COLLEEN WALKER, D.O., LYDIA MURPHY, R.N., B.S.N, and TIMOTHY J. CRAIG,
D.O.
The treatment of atopic dermatitis is directed at correcting
underlying skin abnormalities such as xerosis, pruritus, superinfection and
inflammation. Lubricants, antihistamines and topical corticosteroids are the
mainstays of therapy. |
|
Patient information:
"Eczema--A Skin Problem," p. 1209 |
|
Departments |
| 1073 |
Inside AFP
|
| 1081 |
Newsletter |
| 1084 |
Quantum Sufficit
|
| 1089 |
Clinical Quiz
|
| 1092 |
Editorials
- Is Raloxifene the Answer to the HRT
Story?
- Home Telemedicine: Merging the Old and New
Ways
|
| 1101 |
Letters to the
Editor
- Clinical Pharmacology of Mirtazapine:
Revisited
- Antihypertensive Treatment and CHD in the
Elderly
|
| 1108 |
CME
Calendar |
| 1127 |
Diary from a Week in
Practice
WALTER L. LARIMORE, M.D., JOHN R.
HARTMAN, M.D., THERESA B. SHUPE, M.D., STEPHANIE E. FRISBEE, M.D., J. SCOTT
RIES, M.D., and CHAD A. GRIFFIN, M.D. |
| 1213 |
Conference
Highlights |
| 1220 |
Tips from Other
Journals |
| 1240 |
Family Practice
International |
| 1242 |
Special Medical
Reports
- AAP Report Discusses Success Factors for
Pediatric Call Centers
- ACOG Urges a Cautious Approach to Vaginal
Birth After Cesarean Delivery
|
| 1248 |
Clinical Briefs
|
| 1257 |
Subscription Change of
Address Form |
| 1258 |
Core Educational
Guidelines |
| 1265 |
Physician's
Bookshelf |
| 1269 |
Information for
Authors
|
| 1272 |
Medical Products
and Services |
| 1273 |
Classified
Information |
Copyright © 1999 by the American Academy of
Family Physicians.
This content is owned by the AAFP. A person viewing it
online may make one printout of the material and may use that printout only for
his or her personal, non-commercial reference. This material may not otherwise
be downloaded, copied, printed, stored, transmitted or reproduced in any
medium, whether now known or later invented, except as authorized in writing by
the AAFP.
